ORCL ORACLE CORP

Price Chart

Executive Summary

JP Morgan upgraded ORCL (ORACLE CORP) from Neutral to Overweight on March 11, 2026, but cut its price target to $210 from $230, implying a 7% downside from the current $225.78. The move is part of a broader cluster of 18 firms acting on ORCL, including B of A Securities, Citigroup, and Scotiabank, though most recent actions have been maintains or reiterates. Consensus remains heavily bullish with 41 of 52 analysts at Buy or Strong Buy, a mean target of $244.03, and a high of $400 from Guggenheim. JP Morgan's 57% accuracy on 7 ORCL calls is above average but below top-tier firms like Oppenheimer (100% on 2 calls) and WestPark Capital (100% on 2 calls). The upgrade is contrarian relative to the PT cut and current price above the new target, creating a mixed signal. EPS revisions over the past 30 days show 2 downgrades for the current quarter but 2 upgrades for the current fiscal year, suggesting near-term caution with longer-term optimism. Insider activity is limited to one $2.6M sell by Levey Stuart on April 16, 2026, which is a weak signal per academic literature. The next earnings report is due June 9, 2026, within 30 days, adding a timing catalyst. Bottom line: the upgrade from a mid-tier firm with a below-market PT is a modest positive but not a strong buy signal given the price target cut and consensus already bullish.

Impact Score

Consensus & Targets

Consensus is heavily bullish: 17 Strong Buy, 24 Buy, 10 Hold, 1 Sell, 0 Strong Sell — 78.8% Buy/Strong Buy across 52 analysts. The direction is strongly positive, with only one bearish analyst, making this upgrade largely consensus-aligned.

Mean target is $244.03, median $228, high $400 (Guggenheim), low $155. Current price $225.78 implies 8.1% upside to mean. JP Morgan's $210 target is 13.9% below the mean and 7.9% below the median, making it one of the more bearish targets among the bullish consensus.

Recent Analyst Activity

30-day analyst activity shows 0 upgrades and 0 downgrades, indicating a quiet period. EPS revisions: current quarter saw 2 downgrades in 30 days, while current fiscal year saw 2 upgrades, suggesting near-term caution but longer-term optimism. The upgrade from JP Morgan is a lone positive in an otherwise stable analyst landscape.

Firm Track Record — JP Morgan

JP Morgan accuracy: 55% on 5703 calls | avg return: 5.6%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

JP Morgan has 57% accuracy on 7 ORCL calls with a 4.5% average return, ranking above average but below top-tier firms. Best performing: Oppenheimer (100% on 2 calls, 16.8% avg return) and WestPark Capital (100% on 2 calls, 50.7% avg return). Worst performing: Evercore ISI Group (60% on 10 calls, 2.2% avg return). JP Morgan's call is less reliable than the top firms.

Earnings Estimates

Next earnings: Jun 9, 2026

Cross-Platform Signals

Insider trades: one $2.6M sell by Levey Stuart on April 16, 2026 — a weak signal per academic literature (insider sales are not predictive). Congressional activity: one buy (Ro Khanna, $1K-$15K) and three sells (Jared Moskowitz, $1K-$50K) — small amounts, non-informative. Institutional: Two Sigma doubled position (+1369.6%), Norges Bank new $4.3B position, but Causeway and Mawer exited. Short interest ratio is 60.4%, elevated and bearish. The analyst upgrade diverges from high short interest and insider selling.

Documents Analyzed

Report based on filing metadata.

US Market Status